ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Yuying Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2182-7210; OpenAlex author ID A5100685990. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis. Last author DOI 10.1126/sciadv.adw9519 ↗
Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. First author DOI 10.1038/s41556-022-00857-4 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gang Yang · 1 shared paper, 2025 · strength 0.21
- Paper RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis. DOI 10.1126/sciadv.adw9519 ↗
Yuanyang Wang · 1 shared paper, 2025 · strength 0.21
- Paper RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis. DOI 10.1126/sciadv.adw9519 ↗
Taiping Zhang · 1 shared paper, 2025 · strength 0.21
- Paper RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis. DOI 10.1126/sciadv.adw9519 ↗
Bo Huang · 1 shared paper, 2022 · strength 0.13
- Paper Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. DOI 10.1038/s41556-022-00857-4 ↗
Yabo Zhou · 1 shared paper, 2022 · strength 0.13
- Paper Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. DOI 10.1038/s41556-022-00857-4 ↗
Jiadi Lv · 1 shared paper, 2022 · strength 0.13
- Paper Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. DOI 10.1038/s41556-022-00857-4 ↗
Wei‐Min Tong · 1 shared paper, 2022 · strength 0.13
- Paper Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. DOI 10.1038/s41556-022-00857-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.